Bay Colony Advisory Group, Inc D Sc Pharmaceuticals Inc. Transaction History
Bay Colony Advisory Group, Inc D
- $682 Million
- Q2 2025
A detailed history of Bay Colony Advisory Group, Inc D transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Bay Colony Advisory Group, Inc D holds 10,795 shares of SCPH stock, worth $49,980. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,795Holding current value
$49,980% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding SCPH
# of Institutions
94Shares Held
36.5MCall Options Held
121KPut Options Held
2K-
Orbimed Advisors LLC San Diego, CA6.06MShares$28.1 Million0.5% of portfolio
-
Rubric Capital Management LP New York, NY4.78MShares$22.1 Million0.36% of portfolio
-
Aigh Capital Management LLC Baltimore, MD3.87MShares$17.9 Million8.33% of portfolio
-
King Luther Capital Management Corp Fort Worth, TX3.54MShares$16.4 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.99MShares$9.23 Million0.0% of portfolio
About scPharmaceuticals Inc.
- Ticker SCPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,402,100
- Market Cap $127M
- Description
- scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...